November 1, 2025 · Form 4 insider transaction
Caudill Cortney bought 9,326 shares of Halozyme Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 48 days after the transaction.